FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

IntegraDose Compounding Services ceFAZolin 3 G in 0 Recall

ceFAZolin 3 G in 0

IntegraDose Compounding Services LLC · Minneapolis, MN

Risk level
Class II
Reported by FDA
Oct 6, 2021
Recall ID
D-0897-2021
Check your lot numberHow we source this data

Summary

IntegraDose Compounding Services recalled ceFAZolin 3 G in 0 starting Sep 17, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0897-2021 on Oct 6, 2021. Reason: Lack of sterility assurance. Status: Terminated.

Why it was recalled

Lack of sterility assurance.

Product description

ceFAZolin 3 G in 0.9% Sodium Chloride, 115 mL Bag for Injection, Sterile Product, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC: 71139-7153-1

Lot numbers, UPCs & expiration codes

Lot, expiry: 20210722CEF-2, exp 09/20/2021; 20210728CEF-1, exp 09/26/2021

Where it was sold

NH, MA, MN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0897-2021
Classification
Class II
Status
Terminated
Recall initiated
Sep 17, 2021
FDA report date
Oct 6, 2021
Quantity
589 bags
Recall type
Voluntary: Firm initiated
Recalling firm
IntegraDose Compounding Services LLC

Original FDA data

Every field from FDA enforcement report D-0897-2021, exactly as published.

Show all FDA fields
City
Minneapolis
State
MN
Status
Terminated
Country
United States
Event ID
88731
Address
719 Kasota Ave Se
Code information
Lot, expiry: 20210722CEF-2, exp 09/20/2021; 20210728CEF-1, exp 09/26/2021
Postal code
55414-2842
Report date
Oct 6, 2021
Product type
Drugs
Recall number
D-0897-2021
Classification
Class II
Recalling firm
IntegraDose Compounding Services LLC
Product quantity
589 bags
Termination date
Oct 2, 2022
Reason for recall
Lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
ceFAZolin 3 G in 0.9% Sodium Chloride, 115 mL Bag for Injection, Sterile Product, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC: 71139-7153-1
Distribution pattern
NH, MA, MN
Recall initiation date
Sep 17, 2021
Initial firm notification
Telephone
Center classification date
Sep 30, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0897-2021, published Oct 6, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls